EditorialDrug policy and human rights in the Middle East and North Africa: Harm reduction, legal environment and public health
References (16)
- et al.
Drug policy and harm reduction in the Middle East and North Africa: The role of civil society
International Journal of Drug Policy
(2016) - et al.
Hashish in Morocco and Lebanon: A comparative study
International Journal of Drug Policy
(2016) - et al.
HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine—Programme description and policy implications
International Journal of Drug Policy
(2007) - et al.
The globalisation of cannabis cultivation: A growing challenge
International Journal of Drug Policy
(2015) - et al.
Implementing opioid substitution in the Arab countries: Experience from Lebanon
International Journal of Drug Policy
(2016) - et al.
The state of harm reduction in MENA: The focus on Iran and Morocco
International Journal of Drug Policy
(2016) - et al.
Islam and harm reduction
International Journal of Drug Policy
(2010) The ‘risk environment’: A framework for understanding and reducing drug-related harm
International Journal of Drug Policy
(2002)
There are more references available in the full text version of this article.
Cited by (2)
Attitudes, beliefs, and knowledge of substance use amongst youth in the Eastern Mediterranean region: A systematic review
2019, Drug and Alcohol DependenceCitation Excerpt :This discrepancy between genders is common in conservative societies and has a significant impact on overall prevalence figures. The various international frameworks used to group countries of this region together face limitations related to politics, language, and socioeconomic variability with the widespread adherence to Islam being a unifying factor (Himmich et al., 2016). Researchers have argued a specificity for research and intervention on substance use in muslim populations, which form the majority in EMR countries (Arfken and Ahmed, 2016).
Buprenorphine Treatment for Opioid Use Disorder: An Overview
2019, CNS Drugs
© 2016 Published by Elsevier B.V.